Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-09-24

FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for a generic spironolactone and hydrochlorothiazide combination product from Sun Pharmaceutical Industries, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone and Hydrochlorothiazide (Spironolactone; Hydrochlorothiazide)

Snippet

SUPPL AP for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE (SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE)